CCC Intelligent Solutions Holdings Inc (NASDAQ:CCCS) is set to release its Q1 2025 earnings on May 6, 2025. The consensus estimate for Q1 2025 revenue is $249.85 million, and the earnings are expected ...

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical technology company delivering intelligent, rapid, ...

Intelligent Bio Solutions Inc. (INBS) announced significant developments in a recent letter to shareholders from President and CEO Harry Simeonidis, reflecting on the company's growth in 2024 and its ...

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical technology company delivering intelligent, rapid, ...

CCC (WA:CCCP) Intelligent Solutions (NYSE:CCCS), a leading provider of cloud-based software solutions for the property and casualty insurance industry, is navigating a complex market landscape ...

Additionally, Intelligent Bio Solutions announced that the U.S. Food and Drug Administration (FDA) has requested a new 510 (k) submission for its Intelligent Fingerprinting Drug Screening System, ...

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

View source version on businesswire.com: https://www.businesswire.com/news/home/20251029293584/en/ The articles, information, and content displayed on this webpage ...

Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year ...